Literature DB >> 3744382

Identification and characterization of the CO17-1A carcinoma-associated antigen.

A H Ross, M Lubeck, Z Steplewski, H Koprowski.   

Abstract

The cell surface antigen defined by monoclonal antibody CO17-1A is sensitive to proteinase K but not to neuraminidase digestion. Immunoprecipitation of two polypeptide chains of 30 and 40 kDa using large amounts of CO17-1A antibody confirmed that the CO17-1A antigen is a protein. The requirement for large quantities of CO17-1A antibody may relate to the binding properties of this antibody, as bivalent but not monovalent (Fab) forms of the antibody bind effectively to carcinoma cells. The 30 kDa form of the CO17-1A antigen was purified by immunoaffinity chromatography using GA733, another monoclonal antibody that recognizes the CO17-1A antigen. Treatment of purified antigen with endoglycosidase F revealed a 25 kDa and a 28 kDa species, demonstrating that the antigen has at least two N-linked oligosaccharide chains. Protease treatment of the purified antigen revealed a 26 kDa protease-resistant polypeptide.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3744382

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  5 in total

1.  Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens.

Authors:  S Szala; Y Kasai; Z Steplewski; U Rodeck; H Koprowski; A J Linnenbach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma.

Authors:  H Mellstedt; J E Frödin; P Ragnhammar; G Masucci; J Shetye; B Christensson; P Biberfeld; J Makower; P Pihlstedt; B Cedermark
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Dose-related comparison of antibody-dependent cellular cytotoxicity with chimeric and native murine monoclonal antibody 17-1A. Improved cytolysis of pancreatic cancer cells with chimeric 17-1A.

Authors:  Y Haga; C L Sivinski; D Woo; M A Tempero
Journal:  Int J Pancreatol       Date:  1994-02

4.  Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].

Authors:  Michael Mitas; Loretta Hoover; Gerard Silvestri; Carolyn Reed; Mark Green; Andrew T Turrisi; Carol Sherman; Kaidi Mikhitarian; David J Cole; Mark I Block; William E Gillanders
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

5.  Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1.

Authors:  Y Tomita; F Arakawa; T Yamamoto; M Kuwahara; R Watanabe; H Iwasaki; M Kikuchi; M Kuroki
Journal:  Jpn J Cancer Res       Date:  2000-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.